Printer Friendly

China Sky One Medical granted production licences for 13 new medical products.

M2 EQUITYBITES-April 8, 2011-China Sky One Medical granted production licences for 13 new medical products(C)2011 M2 COMMUNICATIONS

Pharmaceutical company China Sky One Medical Inc (NASDAQ:CSKI) reported on Thursday the receipt of production licences for 13 new medical products in China.

The company and Heilongjiang Traditional Chinese Medical University (HTCMU) jointly obtained production licences for the new medical products from the Heilongjiang Food and Drug Administration.

These 13 new products are: Kang Xi Eye Patch, KangXi Dental Ulcer Membrane, KangXi Anti-virus Mouthwash, KangXi Dental Ulcer Mouthwash, KangXi Snore Stopper, Kang Xi Periarthritis Shoulder Patch, KangXi Cervical Vertebrae Patch, KangXi Lumbar Patch, KangXi Rheumatoid Patch, KangXi Hyperostosis Patch, BiChang Nose Patch, YuFu Scar Patch and YuFu Wound Healing Patch.

Following this approval, China Sky One is preparing for trial production and searching for the best production process for these 13 products, which are expected to be launched as early as the fourth quarter of 2011.

((Comments on this story may be sent to

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Geographic Code:9CHIN
Date:Apr 8, 2011
Previous Article:LDK Solar invests USD40m in Chinese sapphire wafer manufacturing plant.
Next Article:-S&P rates Banco Galicia, upcoming USD300m notes at B.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |